Security Snapshot

Verastem, Inc. - Common Stock (VSTM) Institutional Ownership

CUSIP: 92337C203

13F Institutional Holders and Ownership History from Q2 2023 to Q1 2026

Latest Period

Q4 2025

Institutions Reporting

141

Shares (Excl. Options)

76,499,371

Price

$7.72

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Type / Class
Equity / Common Stock
Symbol
VSTM on Nasdaq
Shares outstanding
66,716,981
Price per share
$5.45
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
76,499,371
Total reported value
$590,570,869
% of total 13F portfolios
0%
Share change
+12,863,919
Value change
+$94,102,234
Number of holders
141
Price from insider filings
$5.45
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Quick Takeaways

  • VSTM - Verastem, Inc. - Common Stock is tracked under CUSIP 92337C203.
  • 141 institutions reported positions in Q4 2025.
  • 17 significant owners is listed from Schedule 13D/13G reporting.

What Changed

  • Holder count moved from 141 to 38 between Q4 2025 and Q1 2026.
  • Reported value moved from $590,570,869 to $49,024,049.

Why This Matters

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Source Evidence

Source: SEC Form 13F

Latest holder context comes from 141 institutions filings for Q4 2025.

Open SEC Evidence

Investment Quick Answers

What is CUSIP 92337C203?
CUSIP 92337C203 identifies VSTM - Verastem, Inc. - Common Stock in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.

Significant Owners of Verastem, Inc. - Common Stock (VSTM) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
RTW INVESTMENTS, LP 9.9% 0% $60,496,591 +$17,057,672 7,836,346 +39% RTW Investments, LP 31 Dec 2025
Deep Track Capital, LP 10% $60,288,436 7,719,390 Deep Track Capital, LP 14 Nov 2025
BALYASNY ASSET MANAGEMENT L.P. 6.2% -35% $36,802,429 -$7,341,998 4,767,154 -17% Balyasny Asset Management L.P. 31 Dec 2025
Nantahala Capital Management, LLC 4.7% -34% $29,301,052 -$6,413,490 3,795,473 -18% Nantahala Capital Management, LLC 31 Dec 2025
BlackRock, Inc. 6% +22% $32,479,205 +$10,231,285 3,676,905 +46% BlackRock, Inc. 30 Sep 2025
ARMISTICE CAPITAL, LLC 5.3% $27,297,920 3,536,000 Armistice Capital, LLC 31 Dec 2025
Polar Capital Holdings Plc 5.1% $36,130,293 3,398,899 Polar Capital Holdings Plc 31 Dec 2025
Soleus Capital Master Fund, L.P. 7.3% $23,421,337 3,350,692 Soleus Capital Management, L.P. 31 Dec 2024
Logos Global Management LP 4.8% -23% $28,035,250 -$2,207,500 3,175,000 -7.3% Logos Global Management LP 30 Sep 2025
Foresite Capital Fund VI LP 5.1% $27,693,456 3,135,120 Foresite Capital Fund VI LP 16 Oct 2025
Stonepine Capital Management, LLC 4.3% -14% $23,576,383 -$1,441,948 2,670,032 -5.8% Stonepine Capital Management, LLC 30 Sep 2025
BIOTECHNOLOGY VALUE FUND L P 3.9% -61% $11,850,000 -$15,266,739 2,500,000 -56% BVF PARTNERS L P/IL 11 Aug 2025
HIRSCHMAN ORIN 3.6% -42% $8,298,970 -$2,960,715 2,003,179 -26% Orin Hirschman 30 Jun 2025
ORBIMED ADVISORS LLC 2.4% -53% $6,319,998 -$7,248,005 1,333,333 -53% ORBIMED ADVISORS LLC 30 Jun 2025
Alyeska Investment Group, L.P. 2.1% $6,990,000 1,000,000 Alyeska Investment Group, L.P. 31 Dec 2024
Point72 Asset Management, L.P. 1.3% -80% $7,681,601 -$18,090,994 995,026 -70% Point72 Asset Management, L.P. 31 Dec 2025
Soleus Private Equity Fund III, L.P. 1.8% $6,541,375 935,819 Soleus Capital Management, L.P. 31 Mar 2025

As of 31 Dec 2025, 141 institutional investors reported holding 76,499,371 shares of Verastem, Inc. - Common Stock (VSTM). This represents 115% of the company’s total 66,716,981 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Verastem, Inc. - Common Stock (VSTM) together control 95% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
RTW INVESTMENTS, LP 9.9% 6,576,306 +21% 0.51% $50,769,082
Deep Track Capital, LP 8.6% 5,740,850 1% $44,319,362
BlackRock, Inc. 7.1% 4,752,842 +28% 0% $36,691,941
VANGUARD GROUP INC 6.2% 4,152,706 +19% 0% $32,058,890
Polar Capital Holdings Plc 5.9% 3,925,126 +271% 0.14% $30,301,973
ARMISTICE CAPITAL, LLC 5.3% 3,536,000 +69% 0.67% $27,297,920
STATE STREET CORP 4.8% 3,219,295 +44% 0% $24,852,957
Balyasny Asset Management L.P. 4.8% 3,195,726 -23% 0.05% $24,671,005
Foresite Capital Management VI LLC 4.7% 3,135,120 +20% 7.3% $24,203,126
Stonepine Capital Management, LLC 4.1% 2,732,079 +2.3% 17% $21,091,650
CITADEL ADVISORS LLC 3.5% 2,353,465 +1173% 0.01% $18,168,750
FARALLON CAPITAL MANAGEMENT LLC 3% 2,000,000 0.09% $15,440,000
SymBiosis Capital Partners, LLC 3% 2,000,000 0% 16% $15,440,000
MORGAN STANLEY 2.8% 1,871,562 +18% 0% $14,448,459
Rosalind Advisors, Inc. 2.7% 1,788,475 -7.3% 5.3% $13,807,027
Logos Global Management LP 2.5% 1,700,000 -58% 0.87% $13,124,000
GOLDMAN SACHS GROUP INC 2.2% 1,495,424 +504% 0% $11,544,673
ACORN CAPITAL ADVISORS, LLC 2.2% 1,469,153 +88% 3.8% $11,341,861
GEODE CAPITAL MANAGEMENT, LLC 2.1% 1,392,822 +12% 0% $10,755,389
NEXTBio Capital Management LP 2% 1,307,330 0% 5.9% $10,092,588
Vivo Capital, LLC 1.7% 1,106,524 -58% 0.55% $8,542,365
TANG CAPITAL MANAGEMENT LLC 1.6% 1,069,810 +35% 0.41% $8,258,933
Point72 Asset Management, L.P. 1.5% 995,026 -74% 0.01% $7,681,601
J. Goldman & Co LP 1.4% 947,303 +129% 0.28% $7,313,179
FRANKLIN RESOURCES INC 1.4% 926,011 0% $7,148,805

Institutional Holders of Verastem, Inc. - Common Stock (VSTM) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 9,249,514 $49,024,049 +$11,017,502 $5.30 38
2025 Q4 76,499,371 $590,570,869 +$94,102,234 $7.72 141
2025 Q3 59,623,619 $526,453,168 +$99,234,089 $8.83 117
2025 Q2 52,579,871 $218,248,088 +$27,001,542 $4.15 108
2025 Q1 43,276,151 $260,961,400 +$53,029,028 $6.03 98
2024 Q4 33,863,058 $175,077,129 +$45,200,535 $5.17 90
2024 Q3 26,590,058 $80,398,256 +$34,219,258 $2.99 76
2024 Q2 14,536,365 $43,320,696 -$62,700,412 $2.98 66
2024 Q1 16,867,597 $198,997,762 +$3,544,853 $11.80 69
2023 Q4 16,678,830 $135,764,956 -$559,497 $8.14 57
2023 Q3 16,747,399 $136,152,780 +$6,463,854 $8.13 56
2023 Q2 16,115,155 $119,896,447 +$119,896,447 $7.44 59
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .